GLOSSARY ENTRY (DERIVED FROM QUESTION BELOW) | ||||||
---|---|---|---|---|---|---|
|
23:18 Apr 13, 2020 |
English to Spanish translations [PRO] Medical - Medical: Pharmaceuticals | |||||||
---|---|---|---|---|---|---|---|
|
| ||||||
| Selected response from: Chema Nieto Castañón Spain Local time: 19:39 | ||||||
Grading comment
|
Adjudicación Explanation: Considerando que el MAA es un acuerdo. Revisando un ejemplo de un MAA, establece que el propósito del acuerdo es establecer los términos acordados y las condiciones para que los pacientes puedan accesar un medicamento. Reference: http://www.nice.org.uk |
| |
Login to enter a peer comment (or grade) |
comisionar [los servicios -sanitarios- relativos al nusinersen] Explanation: Término utilizado dentro de la NHS Manual Oxford de especialidades médicas Escrito por Nina Hjelde, Charlotte Goumalatsou https://books.google.es/books?id=xqGSDwAAQBAJ&pg=PT539&lpg=P... "Commissioning is the process of assessing needs, planning and prioritising, purchasing and monitoring health services, to get the best health outcomes." https://www.england.nhs.uk/commissioning/ |
| |
Login to enter a peer comment (or grade) |
operativizar el proceso de acceso (al NHS) Explanation: Aquí commissioning parece hacer referencia al proceso general de evaluación, planificación, implementación y seguimiento relacionado con la decisión de entrada al NHS de un nuevo fármaco, en este caso mediante un MAA (Managed Access Agreement; acuerdo condicionado de entrada al mercado / acuerdo de entrada al mercado en innovación farmacéutica). No sería tanto así una recomendación de adjudicación (señalamiento de un adjudicatario en un proceso selectivo de compra) sino una recomendación de operativización del proceso mismo conducente a la adquisición y utilización de un nuevo fármaco por parte del NHS. Commissioning comprises a range of activities, including: assessing needs planning services procuring services monitoring quality. https://www.kingsfund.org.uk/publications/what-commissioning... NICE offers draft recommendations and invites comments from health professionals and members of the public. These will be considered and if there are no appeals upheld, NICE will issue the recommendations as NICE final guidance. (...) 1. YES- NICE recommend the drug and it will enter routine commissioning and become available on the NHS. 2. NO- NICE do not recommend the drug, and the NHS is therefore not obligated to make this drug available. 3. The drug is recommended for use only within a Managed Access Agreement (MAA). This option is used when the committee believe the drug has promising potential to be effective, but there are remaining uncertainties about how well the drug performs and whether it is value for money for the NHS. https://www.google.com/url?sa=t&source=web&rct=j&url=https:/... Así, por ejemplo, Las directrices NICE, con la recomendación de operativizar el proceso de acceso [al NHS] de nusinersen mediante un acuerdo condicionado de entrada al mercado (MAA) [acuerdo de entrada al mercado en innovación farmacéutica; Managed Access Agreement] (...) |
| |
Grading comment
| ||
Login to enter a peer comment (or grade) |
Login or register (free and only takes a few minutes) to participate in this question.
You will also have access to many other tools and opportunities designed for those who have language-related jobs (or are passionate about them). Participation is free and the site has a strict confidentiality policy.